Category:

Disaster & Management

COVID-19 long-term toll signals billions in healthcare costs ahead

Bruce Lee of the City University of New York (CUNY) Public School of Health estimated that if 20% of the U.S. population contracts the virus, the one-year post-hospitalization costs would be at least $50 billion, before factoring in longer-term care for lingering health problems. Without a vaccine, if 80% of the population became infected, that cost would balloon to $204 billion.

Some countries hit hard by the new coronavirus – including the United States, Britain and Italy – are considering whether these long-term effects can be considered a “post-COVID syndrome,” according to Reuters interviews with about a dozen doctors and health economists.

read more

Moral challenges ahead of developing & distributing a COVID-19 vaccine 

The newly published “Ethics and Pandemics,” an anthology edited by philosophy professor Meredith Schwartz of Ryerson University in Toronto, presents contrasting views of academics, doctors and commentators along with a series of impossibly difficult case studies. The scientific, economic and political choices involve moral issues that have divided ethicists for centuries.

read more

Australia’s Victoria declares disaster, sets curfew to curb COVID-19

“The current rules have avoided thousands and thousands of cases each day, and then thousands of people in hospital and many more tragedies than we have seen. But it is not working fast enough,” Victoria Premier Daniel Andrews told a televised briefing.

A curfew from 8 p.m. to 5 a.m. every day will be implemented from Sunday evening in Melbourne, barring the nearly five million people in the city from leaving their houses except for work or to receive or give care.

read more

Bihar flood situation worsens, 53.67 lakh people across 14 districts affected

With 16.89 lakh flood-affected people, Muzaffarpur is the worst-hit district, followed by 12.40 lakh people in Darbhanga and 8.09 lakh in East Champaran.

More than half of the affected populace live in Muzaffarpur and Darbhanga districts.

Of the 13 deaths in flood-related incidents, Darbhanga registered the highest seven casualties, followed by four in West Champaran and two in Muzaffarpur.

read more

U.S.makes deal for 100 million doses of coronavirus vaccine, deaths expected to rise

The U.S. Centers for Disease Control on Friday forecast between 168,000 and 182,000 total fatalities by August 22, predicting that deaths will rise fastest in Alabama, Kentucky, New Jersey, Puerto Rico, Tennessee and Washington state.
Coronavirus deaths in the United States are rising at their fastest rate since early June. Roughly one American died about every minute from COVID-19 on Wednesday.

read more

India’s coronavirus cases rise by a daily record of 55,078, death toll at 35,747

Covid-19 infections in the country jumped by 55,078 in the past 24 hours, while the death toll rose by 779 to 35,747, the Ministry of Health and Family Welfare said on its website.Maharashtra has reported its highest single-day spike of 11,147 cases and its tally now stands at 4,11,798. Tamil Nadu’s corona tally has shot up to  239,978 with 5,864 fresh cases. Both states have extended their lockdowns until August 31, with some relaxations.
India’s Covid-19 recovery rate now stands at 64.54 per cent, said Union Health Minister Dr Harsh Vardhan here on Friday.

read more

Southeast Asia poverty to surge in ‘socio-economic crisis’:U.N.

“Without alternative income, formal social protection systems or savings to buffer these shocks, workers and their families will be pushed into poverty, reversing decades of poverty reduction.”
The region-wide economy was expected to contract by 0.4 per cent in 2020, it said, while remittances from Southeast Asians working abroad were likely to fall by 13 per cent or $10 billion.

read more

Gilead raises sales outlook to include COVID-19 treatment remdesivir

Demand for remdesivir continues to outstrip supply in many parts of the world.

Gilead’s chief executive, Daniel O’Day, on a conference call, said the company expects by the end of September to be producing enough remdesivir to meet real-time global demand.

Gilead said it still expects to manufacturer 2 million or more remdesivir treatment courses cumulatively in 2020, and its revenue outlook reflects expected sales of up to 1.5 million courses this year.

read more